PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
3.220
-0.240 (-6.94%)
Dec 20, 2024, 4:00 PM EST - Market closed
PolyPid Market Cap
PolyPid has a market cap or net worth of $21.91 million as of December 20, 2024. Its market cap has increased by 216.04% in one year.
Market Cap
21.91M
Enterprise Value
22.39M
1-Year Change
216.04%
Ranking
Category
Stock Price
$3.22
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $21.91M, a decrease of -73.42%. That is a compound annual growth rate of -25.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 21.91M | 248.65% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | 183.09M | 122.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gelteq | 24.47M |
| Akari Therapeutics, | 24.14M |
| Anebulo Pharmaceuticals | 24.12M |
| Co-Diagnostics | 23.81M |
| Cara Therapeutics | 23.75M |
| Cocrystal Pharma | 23.60M |
| NeuroOne Medical Technologies | 23.44M |
| Vivos Therapeutics | 22.97M |